{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Parsippany",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "87452",
      "recalling_firm": "Teva Pharmaceuticals USA",
      "address_1": "400 Interpace Pkwy",
      "address_2": "N/A",
      "postal_code": "07054-1120",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distributed Nationwide in the USA.",
      "recall_number": "D-0309-2021",
      "product_description": "Romidepsin Injecton, 27.5 mg/5.5 mL (5 mg/mL) Rx Only, 5.5 ml vial, Teva Pharmaceuticals USA, Inc. NDC 0703-4004-01",
      "product_quantity": "1,416 vials",
      "reason_for_recall": "Failed Impurity/Degradation Specifications: Out-of-specifications results observed for impurities during stability testing.",
      "recall_initiation_date": "20210304",
      "center_classification_date": "20210319",
      "termination_date": "20220519",
      "report_date": "20210324",
      "code_info": "Lot # 31328184C, exp. date 11/2021  Lot # 31327686C, exp. date 08/2021  Lot # 31327685C, exp. date 08/2021"
    }
  ]
}